Myomo, Inc.

NYSE American MYO

Myomo, Inc. Market Capitalization on January 14, 2025: USD 203.86 M

Myomo, Inc. Market Capitalization is USD 203.86 M on January 14, 2025, a 91.33% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Myomo, Inc. 52-week high Market Capitalization is USD 235.53 M on January 07, 2025, which is 15.54% above the current Market Capitalization.
  • Myomo, Inc. 52-week low Market Capitalization is USD 75.71 M on April 15, 2024, which is -62.86% below the current Market Capitalization.
  • Myomo, Inc. average Market Capitalization for the last 52 weeks is USD 122.05 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NYSE American: MYO

Myomo, Inc.

CEO Mr. Paul R. Gudonis
IPO Date June 12, 2017
Location United States
Headquarters 137 Portland Street
Employees 101
Sector Technology
Industries
Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Similar companies

IRIX

IRIDEX Corporation

USD 1.61

-1.23%

SSKN

STRATA Skin Sciences, Inc.

USD 2.95

0.00%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

VVOS

Vivos Therapeutics, Inc.

USD 5.06

4.33%

NXL

Nexalin Technology, Inc.

USD 2.78

10.76%

BJDX

Bluejay Diagnostics, Inc.

USD 3.36

-7.95%

NUWE

Nuwellis, Inc.

USD 1.05

3.96%

HSCS

Heart Test Laboratories, Inc.

USD 3.26

1.24%

SINT

Sintx Technologies, Inc.

USD 3.21

-4.46%

RSLS

ReShape Lifesciences Inc.

USD 4.66

-6.80%

NVNO

enVVeno Medical Corporation

USD 3.14

-1.57%

StockViz Staff

January 15, 2025

Any question? Send us an email